Help manage the skin symptoms and joint pain of psoriatic arthritis with one effective treatment.
Psoriatic arthritis is a chronic disease of the immune system. In people with the condition, certain immune cells are activated and produce too much of a protein that causes skin cells to grow too quickly and form raised, red patches, often with silvery scales, known as psoriatic lesions. Excess amounts of this protein can also cause inflamed and painful joints, which can become progressively damaged, especially if the condition is left untreated.
Treatment options for this condition include biologic medications like ENBREL. ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in patients with psoriatic arthritis. In a medical study, participants taking ENBREL showed significant improvements in several measures of arthritis disease activity. In the same study, patients also saw fewer skin symptoms. ENBREL was shown to be effective in about 50% of psoriatic arthritis patients who used it. Clinical responses were apparent at the time of the first visit (4 weeks) and were maintained through 6 months of therapy. Learn more about how ENBREL may help you.
Because ENBREL works on your immune system, it may lower your ability to fight infections and may raise other safety concerns. If you have any signs of an infection, including a fever, cough, or flu-like symptoms, or have any open sores on your body, call your doctor.
Please see Prescribing Information, Important Safety Information, and Medication Guide for complete details about ENBREL..
Like those with psoriatic arthritis, people with rheumatoid arthritis may experience pain, stiffness, and swelling of the joints. Additionally, psoriatic arthritis patients may also have skin lesions similar to those seen in patients with plaque psoriasis. If you have symptoms that affect your skin or your joints, or if both are affected, you should find a specialist near you to discuss your condition as early as possible.
Find a Qualified Specialist
Terms & conditions
Prescription ENBREL is taken by injection.
ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in patients with moderate to severe rheumatoid arthritis. ENBREL can be taken with methotrexate or used alone.
ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in patients with psoriatic arthritis. ENBREL can be used in combination with methotrexate in patients who do not respond adequately to methotrexate alone.
ENBREL is indicated for the treatment of adult patients (18 years or older) with chronic moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
- In medical studies, ENBREL was shown to be clinically effective in about 2 out of 3 adults with moderate to severe RA at 3 months. ENBREL has been shown to begin working in as few as 2 weeks, and most patients who benefit will do so within 3 months. In another medical study, 55% of patients who were evaluated 5 years after beginning ENBREL therapy had no further progression of joint damage.
- ENBREL was shown to be effective in about 50% of patients at 6 months. Clinical responses were apparent at the time of the first visit (4 weeks) and were maintained through 6 months of therapy.
- In medical studies, nearly half of patients saw 75% skin clearance in 3 months. Overall, 3 out of 4 patients saw 50% skin clearance in 3 months.